Market Overview

UPDATE: Bank of America Initiates Cepheid at Buy on Prospects, Platform

Related CPHD
Stocks Hitting 52-Week Lows
Mid-Morning Market Update: Markets Mostly Flat; General Motors Earnings Top Expectations

Bank of America initiated coverage on Cepheid (NASDAQ: CPHD) with a Buy rating and a $40 price objective.

Bank of America noted, "With one of the largest available test menus and more on the way, CPHD's prospects for increasing its installed base and reagent pull-through is positive, as it will become increasingly difficult for customers to justify supporting multiple platforms that run a limited number of tests. As more labs convert to MDx testing, we see CPHD as well positioned to grow. Moreover, our checks suggest that CPHD should see some success as it engages the MDx heavyweights in more established segments of the market (eg, CT/NG)."

Cepheid closed at $32.63 on Friday.

Latest Ratings for CPHD

Nov 2015Stifel NicolausInitiates Coverage onBuy
Oct 2015Canaccord GenuityDowngradesSpeculative BuyHold
Oct 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Initiation Pre-Market Outlook Analyst Ratings


Related Articles (CPHD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters